[Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D004352:Drug Resistance, Microbial; D006801:Humans; D007223:Infant; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D012306:Risk; D013997:Time Factors; D014777:Virus Diseases / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents
Su alcuni aspetti etio-patogenetici e terapeutici della infezione respiratoria cronica nella fibrosi cistica.